RATIONALE: Eicosanoids are fatty acid oxides which are metabolized from arachidonic acids by oxidase such as cyclooxygenase (COX), lipoxygenase (LOX), and epoxygenase, and it has been known that the abnormal activation of arachidonic pathway is association with the occurrence of asthma. We aimed to identify novel effective metabolite marker that distinguish refractory asthma and find out the etiology of refractory asthma. METHODS: Peripheral blood was obtained from 4 subjects of control group, 56 subjects with non-refractory asthma, and 48 subjects with refractory asthma. Refractory asthma was defined as asthma that requires treatment with high dose inhaled corticosteroids to control, and when patients had two or more acute exacerbations within 12 months, or persistent decreased lung function (predicted value of forced expiratory volume in 1 second<80%). Simultaneous measurements of 43 multiple eicosanoid biomarker panels were performed using liquid chromatography(LC)-mass spectrometry(MS)/MS analysis. RESULTS: Among 42 eicosanoids, the mean levels of PGJ2 (p50.035), LTB4 (p50.009), S5HETE (p50.002), 5-oxo-ETE (p50.005), 12-oxo-ETE (p50.006), and LXA4 (p50.008) were significantly increased in refractory asthma group than in non-refractory asthma group. Among 48 refractory asthmatics, 36 showed frequent exacerbations and 26 showed airway remodeling. The former 6 eicosanoids were increased in frequent exacerbation group, while patients with airway remodeling showed no difference in any eicosanoid. In non-refractory asthma group, the presence of atopy increased the level of 6 eicosanoids. CONCLUSIONS: Eicosanoids metabolized by LOX and COX pathway were increased in refractory asthmatics, especially in frequent exacerbators. Increased eicosanoids in non-atopic asthmatics may be a predictor of frequent exacerbation. RATIONALE: Accumulating evidence suggests that environmental experiences in the first months of life may lead to progression of various allergic diseases through sensitization to aeroallergens as well as food allergens. Prevention of IgE sensitization in this period is therefore theorized to reduce the future risk of allergy development. We aimed to clarify whether administration of anti-IgE to pregnant mice can prevent allergic sensitization in offspring. METHODS: Pregnant mice were injected intravenously with 100 mg of anti-mouse IgE or isotype control at embryonic 12.5 days (E12.5) and E18.5. OVA emulsified with alum was injected intraperitoneally to offspring beginning on postnatal day 2 (PND2), 16, 30 and 44, twice with a one-week interval, and sera were collected 14 days after the second immunization. Spleen cells from the offspring were cultured with OVA for 3 days. The levels of OVA-specific immunoglobulins in the sera and cytokines in the culture supernatants were determined by ELISA. Each mouse was intraperitoneally challenged with OVA, and the body temperature was measured. RESULTS: When pregnant C57BL/6 mice were administered anti-IgE, production of OVA-specific IgE antibodies was suppressed even in offspring immunized at PND44. In BALB/c mice, suppression was seen in offspring immunized at PND2, but not at the later ages. In both mouse strains, the manifestations associated with antigen challenge of sensitized infants were ameliorated by the treatment. However, the serum levels of IgG-class antibody and cytokine production from spleen cells in the offspring were not altered. CONCLUSIONS: Administration of anti-IgE to pregnant mice suppressed allergic sensitization in their offspring. Marshfield Clinic Research Institute, Marshfield, WI. RATIONALE: Early life farm exposure is associated with protection against development of atopic disease and severe respiratory infections. However, the impact of early life farm exposure on immune cell profiles and antiviral maturation on respiratory viral burden remains poorly characterized. We hypothesized that early life farm exposure is associated with differences in the innate immune cell signatures. METHODS: Longitudinally collected blood mononuclear cells from cord (n5108; [non-farm564;farm544]) and 1-year old (n591; [non-farm-550;farm541]) animal farm-exposed and non-farm rural infants enrolled in Wisconsin Infant Study Cohort were stimulated with rhinovirus A16 (RV) or lipopolysaccharide (LPS) and analyzed with two multiparameter flow cytometry panels. Statistical analysis was performed using Prism 7, SPICE v6, and Qlucore Omics Explorer v3.4. RESULTS: Using principal component analysis, significant age-related differences were seen with both RV and LPS stimulation at 1-year of age compared to cord blood (71 variables and 70 variables, respectively, qvalue < _0.05). Monocyte cytokine responses to LPS had a higher frequency of single and dual cytokine producing cells in farm-exposed children compared to non-farm children at 1-year of age (p50.024). In contrast, RVinduced plasmacytoid dendritic cell function was similar between farm and non-farm infants irrespective of age. CONCLUSIONS: Innate immune cell responses exhibit maturational changes during the first year of life and early life farm exposures are associated with increased monocyte polyfunctionality at 1-year of age. Studies are ongoing to elucidate innate immune signature associations with specific farm-related early life exposures, atopic disease and respiratory viral disease burden. 
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